{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T10:14:35Z","timestamp":1773137675552,"version":"3.50.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1097\/bs9.0000000000000282","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:00:08Z","timestamp":1773086408000},"page":"e00282","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Identification of two novel TP53 mutations in secondary acute myeloid leukemia following multiple myeloma: a case report"],"prefix":"10.1097","volume":"8","author":[{"given":"Maria Antonia","family":"De Francesco","sequence":"first","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy"},{"name":"Highly Specialized Laboratory, ASST Spedali Civili di Brescia, Brescia 25123, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Ribolla","sequence":"additional","affiliation":[{"name":"Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Sottini","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy"},{"name":"Highly Specialized Laboratory, ASST Spedali Civili di Brescia, Brescia 25123, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Bertoli","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy"},{"name":"Highly Specialized Laboratory, ASST Spedali Civili di Brescia, Brescia 25123, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlotta","family":"Giupponi","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy"},{"name":"Highly Specialized Laboratory, ASST Spedali Civili di Brescia, Brescia 25123, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ottavia","family":"Bonuccelli","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy"},{"name":"Highly Specialized Laboratory, ASST Spedali Civili di Brescia, Brescia 25123, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Bresciani","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy"},{"name":"Highly Specialized Laboratory, ASST Spedali Civili di Brescia, Brescia 25123, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Tucci","sequence":"additional","affiliation":[{"name":"Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Biasiotto","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy"},{"name":"Highly Specialized Laboratory, ASST Spedali Civili di Brescia, Brescia 25123, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"8","key":"R1-20260309","doi-asserted-by":"crossref","first-page":"e30123","DOI":"10.1016\/j.heliyon.2024.e30123","article-title":"Integrating p53-associated genes and infiltrating immune cell characterization as a prognostic biomarker in multiple myeloma.","volume":"10","author":"Lv","year":"2024","journal-title":"Heliyon"},{"issue":"9","key":"R2-20260309","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1016\/S2352-3026(22)00165-X","article-title":"The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends.","volume":"9","author":"Huang","year":"2022","journal-title":"Lancet Haematol"},{"issue":"3","key":"R3-20260309","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"R4-20260309","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1309\/AJCPOP7APGDT9JIU","article-title":"Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.","volume":"138","author":"Reddi","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"R5-20260309","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00277-022-04806-x","article-title":"The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.","volume":"101","author":"Gramegna","year":"2022","journal-title":"Ann Hematol"},{"issue":"3","key":"R6-20260309","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"issue":"26","key":"R7-20260309","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: a report from International Myeloma Working Group.","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol"},{"issue":"9","key":"R8-20260309","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma.","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"issue":"7","key":"R9-20260309","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms.","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"23","key":"R11-20260309","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1093\/bioinformatics\/btx423","article-title":"GLASS: assisted and standardized assessment of gene variations from Sanger sequence trace data.","volume":"33","author":"Pal","year":"2017","journal-title":"Bioinformatics"},{"key":"R12-20260309","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev.biochem.77.060806.091238","article-title":"Structural biology of the tumor suppressor p53.","volume":"77","author":"Joerger","year":"2008","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"R13-20260309","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.bbagen.2012.12.004","article-title":"Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin.","volume":"1830","author":"Berge","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"25","key":"R14-20260309","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1056\/NEJMoa073770","article-title":"TP53 mutations and survival in squamous-cell carcinoma of the head and neck.","volume":"357","author":"Poeta","year":"2007","journal-title":"N Engl J Med"},{"key":"R15-20260309","doi-asserted-by":"crossref","first-page":"772315","DOI":"10.3389\/fcell.2021.772315","article-title":"Oligomerization of Mutant p53 R273H is not required for gain-of-function chromatin associated activities.","volume":"9","author":"Annor","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"R16-20260309","doi-asserted-by":"crossref","first-page":"e432650","DOI":"10.1200\/EDBK_432650","article-title":"Mutations in acute leukemias and myelodysplastic syndromes: insights and treatment updates.","volume":"44","author":"Santini","year":"2024","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"15","key":"R17-20260309","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1182\/blood.2021014472","article-title":"Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.","volume":"139","author":"Grob","year":"2022","journal-title":"Blood"},{"issue":"10","key":"R18-20260309","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/s41591-020-1008-z","article-title":"Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.","volume":"26","author":"Bernard","year":"2020","journal-title":"Nat Med"},{"issue":"21","key":"R19-20260309","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1056\/NEJMoa1605949","article-title":"TP53 and decitabine in acute myeloid leukemia and myelodysplastic syndromes.","volume":"375","author":"Welch","year":"2016","journal-title":"N Engl J Med"},{"issue":"11","key":"R20-20260309","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","article-title":"Cancer therapy shapes the fitness landscape of clonal hematopoiesis.","volume":"52","author":"Bolton","year":"2020","journal-title":"Nat Genet"},{"issue":"16","key":"R21-20260309","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood.2021014956","article-title":"Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms.","volume":"140","author":"Sperling","year":"2022","journal-title":"Blood"},{"issue":"1","key":"R22-20260309","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood.2021013983","article-title":"TP53 copy number and protein expression inform mutation status across risk categories in acute myeloid leukemia.","volume":"140","author":"Tashakori","year":"2022","journal-title":"Blood"},{"issue":"5","key":"R23-20260309","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.molcel.2018.08.013","article-title":"A systematic p53 mutation library links differential functional impact to cancer mutation pattern and evolutionary conservation.","volume":"71","author":"Kotler","year":"2018","journal-title":"Mol Cell"},{"issue":"11","key":"R24-20260309","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.celrep.2019.08.061","article-title":"Integrated analysis of TP53 gene and pathway alterations in the Cancer Genome Atlas.","volume":"28","author":"Donehower","year":"2019","journal-title":"Cell Rep"},{"issue":"1","key":"R25-20260309","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13045-023-01480-y","article-title":"Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia.","volume":"16","author":"Bahaj","year":"2023","journal-title":"J Hematol Oncol"},{"issue":"9","key":"R26-20260309","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/bloodadvances.2021006239","article-title":"TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS\/AML.","volume":"6","author":"Weinberg","year":"2022","journal-title":"Blood Adv"}],"container-title":["Blood Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BS9.0000000000000282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:00:11Z","timestamp":1773086411000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BS9.0000000000000282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/bs9.0000000000000282","relation":{},"ISSN":["2543-6368"],"issn-type":[{"value":"2543-6368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"2025-08-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}